Notice

ARE YOU FAMILIAR WITH THE TERM DDS IN THE FIELD OF DRUG DISCOVERY?

I remember well that when I told him about the use of nanobubbles in fecal microflora transplantation to ensure the delivery of bacteria to the intestines, our advisor, Dr. Tsukamoto, said, “That’s DDS.

DDS IS OFFICIALLY CALLED A DRUG DELIVERY SYSTEM.

WHAT EXACTLY IS DDS?

A technology that aims to maximize drug efficacy and minimize side effects by controlling drug distribution in the body.
That is the definition of DDS.

A medicine is not only about its ingredients and efficacy.
It is important to know “where it works,” “how it works,” and “how long it lasts.

THE CURRENT DRUG DISCOVERY PROCESS IS BASED LARGELY ON THE EXISTENCE OF DDS.

Around the 1980s, artificial organic compounds called small molecule drugs began to dominate drug discovery.
So we have gone from the days of staring at things with a magnifying glass in hand to the artificial manipulation of chemical markings that look like spider webs.

And now.
The world of drug discovery is once again at a major turning point.

The concept of DDS is built into these new drug discoveries by default.
The substance itself that is delivered to the body is important, but the idea is to “educate” the body on how to make it work.

Advisor Tsukamoto sees it this way.

Tsukamoto Advisor

MY THOUGHT IS THAT IT WOULD BE A NATIONAL POLICY TO FOCUS ON DDS RESEARCH OF KNOWN BIOACTIVE SUBSTANCES AS WELL AS THE SEARCH FOR BIOACTIVE SUBSTANCES, AS THIS WILL INCREASE THE PROBABILITY OF DRUG DISCOVERY.

EXHIBITED AT THE JAPAN DDS CONFERENCE

I WOULD LIKE TO TALK ABOUT SYMBIOSIS LABORATORIES’ PARTICIPATION IN THE JAPAN DDS CONFERENCE.

WE ARE COLLABORATING WITH THE DRUG DELIVERY SYSTEMS LABORATORY OF KOBE GAKUIN UNIVERSITY’S FACULTY OF PHARMACEUTICAL SCIENCES, LED BY PROFESSOR TAKEDA, TO SEE IF NANOBUBBLES CAN PLAY A ROLE IN DDS.

ON AUGUST 28 AND 29, 2020, WE PARTICIPATED AS AN EXHIBITOR AT THE 36TH JAPAN DDS CONFERENCE, CHAIRED BY PROFESSOR TAKEDA!

Corona measures were also in place, and Symbiosis gave a two-day online presentation titled “Next-Generation New Materials Nanobubbles that Make Research Blink”.
Researchers Morishita and Shimizu also attended other abstracts at the conference and found them very meaningful.

Drug discovery and disease seem to play a game of fetch.
As drug technology advances, new diseases, new viruses, and resistant bacteria emerge.

May nanobubble technology bring a new wind to the future of medicine.